✦ LIBER ✦

926 Pharmacokinetics (PK), clinical pharmacodynamics (PD) and safety of chronic oral topotecan (T), in a phase I study

✍ Scribed by J.H.M. Schellens; J.R. Eckardt; D.D. von Hoff; G.J. Creemers; C. Gerrits; W.J. Loos; I. Hudson; C. Broom; B.E. Davies; J. Verweij

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

135 A clinical phase I dose escalation,

✍ K. Mross; F. Baas; M. Medinger; J. Drevs; R. Strecker; J. Hennig; M. Wolters; G. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 148 KB

594 A Phase I Dose-escalation, Pharmacok

✍ Bendell, J.; Weiss, G.; Infante, J.; Ramanathan, R.; Jones, S.; Korn, R.; Burris 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 66 KB

940 Phase I and pharmacokinetic study of

✍ V.M.M. Herben; W.W. ten Bokkel Huinink; S. Rodenhuis; J.H. Schornagel; J.H. Beij 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 156 KB

201 POSTER Denosumab safety, pharmacokin

✍ H. Minami; K. Kitagawa; K. Yonemori; Y. Fujiwara; H. Fujii; T. Arai; M. Ohkura; 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB

280 POSTER Phase I study of the safety,

✍ J. Infante; E.C. Dees; R.B. Cohen; H. Burris; B. O'Neil; P. Murphy; Y. Lee; J. P 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 77 KB

1204 A Phase I study evaluating the phar

✍ R. Kristeleit; D. Sarker; M. Forster; M. Lolkema; D. Olmos; K. Mazina; M.V. Dole 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB